FDAClass IIMarch 18, 2026

IBA Proton Therapy System - PROTEUS 235 recall

IBA Proton Therapy System - PROTEUS 235

Why was IBA Proton Therapy System - PROTEUS 235 recalled?

It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a risk of mistreatment when external gating devices are used.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

PROTEUS 235; UDI-DI: 05404013801138; Serial Numbers: SBF103 (JP), SBF124 (EU), SBF133 (US), SBF140 (EU)

Product
IBA Proton Therapy System - PROTEUS 235
Recalling firm
Ion Beam Applications S.A.
Quantity
4 units (1 US, 3 OUS)
Distribution
Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan.
Recall date
March 18, 2026
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls